Skip to main content
. 2022 May 5;40(24):3395–3401. doi: 10.1016/j.vaccine.2022.04.009

Table 1.

Framework for perspectives in health economic evaluations of vaccines and the views of stakeholders in Sweden and other countries about relevant health economic consequences for health economic analysis of vaccine (white = include, black = exclude, grey = divergent opinions/ unknown).

graphic file with name fx1_lrg.gif

TLV = Tandvårds- och läkemedelsförmånsverket (The Swedish Dental and Pharmaceutical Benefits Agency), FoHM = Folkhälsomyndigheten (Public Health Agency of Sweden), STIKO = Standing Committee on Vaccination, JCVI = Joint Committee on Vaccination and Immunisation, ACIP = Advisory Committee on Immunization Practices.

aInclude if it is possible to collect evidence.

bRegions: Include, TLV: Exclude, FoHM: Include production loss morbidity and production loss caregiver. Exclude production loss mortality.

cACIP: Include, STIKO: Include in sensitivity analysis, JCVI: Exclude (health-care perspective).

dNot necessarily a part of the economic analysis but could be part of decision-making.